Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • December 05 2016

    Douglas S. Ellenoff, a member of the Firm, was invited to be a panelist at the the Thirty-Fifth SEC Government–Business Forum on Small Business Capital Formation. The Securities and Exchange Commission has conducted this forum annually since 1982. The event provided small businesses, their advisors, and their investors with an opportunity to share perspectives and views on a variety of topics important to them. This year the Forum focused on how capital formation options are working for small businesses following the implementation of the JOBS Act.

    Click here to view the webcast.  Please fast forward to 47:33 to listen to Mr. Ellenoff’s portion.

  • December 01 2016

    PURE Bioscience Inc. announced the closing of their PIPE offering in the amount of $1,900,000.  EG&S acted as counsel to the Placement Agent.

  • November 30 2016

    Amanda M. Fugazy, a member of the Firm, presented at the HUB Food Service Industry Workshop and prepared the Restaurant Management Employment Law Overview.  Click here to read it.

  • November 30 2016

    Glen Sproviero, an Associate of the Firm, was invitied by Lawline to present a CLE entitled “Federal Criminal Procedure: The Basics”.  The course examined the various stages of a federal criminal prosecution, including the requirements for probable cause, appearances before a magistrate, arraignment, pretrial motions, trial, and sentencing. It also discussed major policy issues such as crime control and due process models of criminal justice, along with ethical considerations and political concerns.

    Click here to view the presentation.

  • November 29 2016

    Bellerophon Therapeutics Inc. announced the closing of their Registered Direct offering in the amount of $12,000.000.  EG&S acted as counsel to the Placement Agent.

  • November 29 2016

    Cellectar Biosciences, Inc. announced the closing of their Underwritten offering in the amount of $9,200,000.  EG&S acted as counsel to the Underwriter.

  • November 29 2016

    Rosetta Genomics Ltd. announced the closing of their PIPE offering in the amount of $3,707,500.  EG&S acted as counsel to the Investor.

  • November 23 2016

    Client Alert: Federal Judge Blocks Implementation

    As we previously advised, on May 18, 2016, the U.S. Department of Labor published the final rule updating the overtime regulations.  Click here to read the full alert.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”